Title: ABO%20Blood%20Group%20System
1ABO Blood Group System October 19, 2004 Steven
L. Spitalnik, M.D. Phone 212-305-2204 email
ss2479_at_columbia.edu Lab PS 15-408
2(No Transcript)
3(No Transcript)
4(No Transcript)
5Hemolytic Transfusion Reactions
6Landsteiner Experiment 1900
Mix serum and RBC from random individuals Incubate
at RT Observe for RBC agglutination
Modern interpretation All humans have
naturally-occurring IgM antibodies to the
carbohydrate ABO antigens they lack
7Landsteiner Experiment 1900
Why do we care? ABO incompatible RBC ?
death ABO incompatible xplant ? hyperacute
rejection We go to extraordinary lengths to
prevent this Every donor and donor unit it ABO
typed every time Every recipient is ABO typed
every time The front and back type must
agree Lots of barriers and requirements from
phlebotomy to transfusion Still we have problems
8Hemolytic Transfusion Reactions
Elliott et al. Visualizing the hemolytic
transfusion reaction. Transfusion 43 297, 2003.
9Hemolytic Transfusion Reactions
Acute HTRs IgM-mediated ABO Clinical course
severe significant mortality Malpractice
10Hemolytic Transfusion Reactions
Acute HTRs 14 x 106 RBC transfused/year in
USA 1000 clinically significant ABO
incompatible transfusions 10 deaths in US from
ABO HTRs Risk of death 1/106 per transfusion
11Hemolytic Transfusion Reactions
Linden et al. Transfusion errors in New York
State an analysis of 10 years experience.
Transfusion 401207-1213, 2000.
12Hemolytic Transfusion Reactions
Linden et al. Transfusion errors in New York
State an analysis of 10 years experience.
Transfusion 401207-1213, 2000.
13Hemolytic Transfusion Reactions
14Hemolytic Transfusion Reactions
RBC IgM
Complement activation
Intravascular hemolysis
Magic happens
Shock, renal failure, death
15Red Blood Cells (RBC) Basic stuff
Biconcave disk Membrane structure Cytoplasm Hgb,
LDH, K No internal membranes No nucleus No RNA No
synthetic capacity Terminally differentiated
16RBC MEMBRANE
17CONSTITUENTS OF THE RBC MEMBRANE
Lipid bilayer phospholipids,
cholesterol Glycosphingolipids Proteins Transm
embrane proteins (RhD) Transmembrane
glycoproteins Single span (Glycophorin
A) Multispan (Band 3) GPI-anchored (DAF)
18LIPID BILAYER (PHOSPHOLIPIDS)
19STRUCTURE OF THE LIPID BILAYER
20STRUCTURES OF PHOSPHOLIPIDS
(CH3)3NCH3CH2O-HPO2-OCH2
\
H2CO-COCH2CH2CH2CH2CH2CH2CH2CH2CH2
CH2CH2CH2CH2CH2CH3
/
H2CO-COCH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2C
H2CH2CH2CH3
(CH3)3NCH3CH2O-HPO2
\
OCH2CHCHCHCHCH2CH2CH2CH2CH2CH2CH2
CH2CH2CH2CH2CH2CH3
/ /
NH OH
/
COCH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2
CH3
21STRUCTURES OF PHOSPHOLIPIDS Lipid tails
HOCH3
\
H2CO-COCH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2C
H3
/
H2CO-COCH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2C
H3
HOCH2CHCHCHCHCH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2CH2
CH3 /
/ NH OH
/
COCH2CH2CH2CH2CH2CH2CH2CH2C
H2CH2CH2CH2CH2CH2CH2CH2CH3
22STRUCTURES OF PHOSPHOLIPIDS Head groups
23STRUCTURES OF PHOSPHOLIPIDS
24GLYCOSPHINGOLIPIDS (GLYCOLIPIDS)
25MONOSACCHARIDE STRUCTURE
Glucose Glc
Numbering Axial vs. equatorial Anomerity a vs. ß
26MONOSACCHARIDE STRUCTURE
ß-Glc
Anomerity a vs. ß
27MONOSACCHARIDE STRUCTURE
a-Glc
Anomerity a vs. ß
28MONOSACCHARIDE STRUCTURE
ß-Glc
Epimers Gal vs. Glc
29MONOSACCHARIDE STRUCTURE
ß-Gal
Epimers Gal vs. Glc
30MONOSACCHARIDE STRUCTURE
L-a-Fuc
Fucose 6-deoxy-L-Gal
31MONOSACCHARIDE STRUCTURE
ß-Glc
Amino sugars N-acetyl-glucosamine
GlcNAc N-acetyl CH3CONH-
32MONOSACCHARIDE STRUCTURE
ß-GlcNAc
33CARBOHYDRATE STRUCTURES
Disaccharides
Glc(ß1-4)GlcNAc
34CARBOHYDRATE STRUCTURES
Type 2 Chain
Gal(ß1-4)GlcNAc
35CARBOHYDRATE STRUCTURES
Type 1 Chain
Gal(ß1-3)GlcNAc
36CARBOHYDRATE STRUCTURES
Type 2 Chain
Gal(ß1-4)GlcNAc
37CARBOHYDRATE STRUCTURES
Gal(a1-4)GlcNAc
38CARBOHYDRATE STRUCTURES
Type 2 Chain
Gal(ß1-4)GlcNAc
39CARBOHYDRATE STRUCTURES
Type 2 H
Fuc(a1-2)Gal(ß1-4)GlcNAc
40(No Transcript)
41GLYCOCONJUGATE BIOSYNTHESIS Glycosidic
bonds Glycosyltransferase
42(No Transcript)
43BIOSYNTHESIS OF BLOOD GROUP A GLYCOLIPID
A TYPE 2
44Glycolipids
45CHARACTERISTICS OF THE A AND B TRANSFERASES
46CHARACTERISTICS OF THE A AND B TRANSFERASES
A (a1-3) GalNAc-transferase (EC 2.4.1.40)
GalNAc(a1-3)
\ UDP-GalNAc
Gal(ß1)-R --gt Gal(ß1)-R
UDP /
/ Fuc(a1-2)
Fuc(a1-2)
B (a1-3) Gal-transferase (EC 2.4.1.37)
Gal(a1-3)
\ UDP-Gal Gal(ß1)-R
--gt Gal(ß1)-R UDP
/
/ Fuc(a1-2)
Fuca(1-2)
47STRUCTURE OF THE A AND B TRANSFERASES
Yamamoto et al. Nature 345229, 1990
48STRUCTURE OF THE A AND B TRANSFERASES
Four Critical Residues
49STRUCTURE OF THE A AND B TRANSFERASES
Four Critical Residues
Yamamoto et al. J Biol Chem 26519257, 1990
50STRUCTURE OF THE A AND B TRANSFERASES
Four Critical Residues
Conclusion The last two critical residues (aa
266 and 268) are very important in determining
specificity
Yamamoto et al. J Biol Chem 26519257, 1990
51CRYSTAL STRUCTURE OF THE B TRANSFERASE
Patenaude et al. Nature Struct Biol 9685, 2002
52ACTIVE SITE OF THE B TRANSFERASE
Patenaude et al. Nature Struct Biol 9685, 2002
53ACTIVE SITES OF THE A AND B TRANSFERASES
GROUP A
GROUP B
Patenaude et al. Nature Struct Biol 9685, 2002
54ABO Histo-blood group system Summary
Carbohydrate antigens
Glycolipids glycoproteins
Indirect gene product
500,000 copies/RBC
On many tissues (histoblood group Ag)
No known function
Naturally occurring IgM
T-independent
Direct agglutinin
C5b-9 membrane attack complex
Intravascular hemolysis
Acute hemolytic transfusion reaction
Hyperacute rejection of solid-organ tranplants
Mild HDN, if any
55ACKNOWLEDGEMENTS
ABO Glycolipids K. Landsteiner Vienna and
Rockefeller E. Kabat Columbia University W.
Watkins Great Britain W. Morgan Great
Britain V. Ginsburg NIH R. Oriol France S.
Hakomori Seattle H. Clausen Seattle F.
Yamamoto Seattle